Home/Filings/4/0001628280-25-044542
4//SEC Filing

Stelmakh Edward 4

Accession 0001628280-25-044542

CIK 0001448431other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 6:25 PM ET

Size

8.9 KB

Accession

0001628280-25-044542

Insider Transaction Report

Form 4
Period: 2025-10-03
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-0316,6230 total
    Common Stock (16,623 underlying)
  • Tax Payment

    Common Stock

    2025-10-03$18.75/sh4,406$82,613122,981 total
  • Exercise/Conversion

    Common Stock

    2025-10-03+16,623127,387 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
  • [F3]The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001887046

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:25 PM ET
Size
8.9 KB